title: Comments on Delanghe and Joyner's editorial "testing for recombinant human erythropoietin". The importance of a strong collaboration between pharmaceutical companies and WADA-accredited laboratories.
authors.forename: Jakob
authors.initials: J
authors.lastname: Mørkeberg
authors.forename: Bo
authors.initials: B
authors.lastname: Belhage
authors.forename: Rasmus
authors.initials: R
authors.lastname: Damsgaard
mesh_terms: D004300:Doping in Sports / Q000379:methods*; D004345:Drug Industry; D004921:Erythropoietin / Q000652:urine*; D006801:Humans; D007753:Laboratories; D011994:Recombinant Proteins
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin